VERU INC. Capital Expenditures Incurred but Not yet Paid
VERU INC. (VERU) reported Capital Expenditures Incurred but Not yet Paid of $190.00 thousand for the 12-month period ending 2018-09-30, per its 10-K filed 2019-12-12.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2019-12-12
- VERU INC. capital expenditures incurred but not yet paid for the quarter ending 2016-09-30 was $1.38K.
- VERU INC. capital expenditures incurred but not yet paid for the quarter ending 2013-03-31 was -$146.91K.
- VERU INC. capital expenditures incurred but not yet paid for the quarter ending 2012-12-31 was $160.72K.
- VERU INC. capital expenditures incurred but not yet paid for the quarter ending 2012-09-30 was -$34.14K.
- VERU INC. capital expenditures incurred but not yet paid for fiscal 2018 was $190.00K.
- VERU INC. capital expenditures incurred but not yet paid for fiscal 2016 was $2.29K.
- VERU INC. capital expenditures incurred but not yet paid for fiscal 2012 was $124.80K.
- VERU INC. capital expenditures incurred but not yet paid for fiscal 2009 was $86.10K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2018-09-30 | $190.00K 10-K · filed 2019-12-12 | |||
| 2017-03-31 | $7.94K 10-Q · filed 2018-05-11 | |||
| 2016-09-30 | $1.38K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-12 | $2.29K 10-K · filed 2016-12-12 | ||
| 2016-06-30 | $920.00 10-Q · filed 2016-07-28 | |||
| 2013-03-31 | -$146.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-01 | $13.81K 10-Q · filed 2014-05-01 | -$20.33K derived: sum of 3 quarters · filed 2014-12-02 | |
| 2012-12-31 | $160.72K 10-Q · filed 2014-02-03 | $126.58K derived: sum of 2 quarters · filed 2014-12-02 | ||
| 2012-09-30 | -$34.14K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-02 | $124.80K 10-K · filed 2014-12-02 | ||
| 2012-06-30 | $158.94K 10-Q · filed 2013-08-01 | |||
| 2009-09-30 | $86.10K 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |